Solr Search

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

eader in industries ranging from agriculture to financial services, tourism, and technology.

ed to technological change in the past and how current innovative projects are supporting adaptation, especially in the private sector.

ilities and broader commercialization ecosystems that contribute to firm expansion, high-skills job creation, and broad economic growth.